Screening compound: NRNZKDKNERLPOB-SFHVURJKSA-N

Screening compound: NRNZKDKNERLPOB-SFHVURJKSA-N
Screening compound: NRNZKDKNERLPOB-SFHVURJKSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
NRNZKDKNERLPOB-SFHVURJKSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M735-1643

Molecular Formula

C25H28N4O4 (C25 H28 N4 O4)

Compound Name

3-(3-{[2-(morpholine-4-carbonyl)phenoxy]methyl}piperidine-1-carbonyl)-1H-indazole

IUPAC name

3-(3-{[2-(morpholine-4-carbonyl)phenoxy]methyl}piperidine-1-carbonyl)-1H-indazole

SMILES

O=C(c1n[nH]c2c1cccc2)N1CC(COc(cccc2)c2C(N2CCOCC2)=O)CCC1

InChI

InChI=1S/C25H28N4O4/c30-24(28-12-14-32-15-13-28)20-8-2-4-10-22(20)33-17-18-6-5-11-29(16-18)25(31)23-19-7-1-3-9-21(19)26-27-23/h1-4,7-10,18H,5-6,11-17H2,(H,26,27)/t18-/m0/s1

InChI Key

NRNZKDKNERLPOB-SFHVURJKSA-N

MDL Number (MFCD)

MFCD29004506

NRNZKDKNERLPOB-SFHVURJKSA-N in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

PI3K-Targeted Library (17255 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Targets:
  • GPCR
  • Kinases
  • Kinases
Structure:
  • Mimetics
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with NRNZKDKNERLPOB-SFHVURJKSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound NRNZKDKNERLPOB-SFHVURJKSA-N?
Check Price and Availability of NRNZKDKNERLPOB-SFHVURJKSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of NRNZKDKNERLPOB-SFHVURJKSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for NRNZKDKNERLPOB-SFHVURJKSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for NRNZKDKNERLPOB-SFHVURJKSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of NRNZKDKNERLPOB-SFHVURJKSA-N available by request